Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
With job security being uncertain across a number of sectors, the American workforce is beginning to look toward career paths beyond their realm of expertise.
Kathryn Minshew, founder and CEO of career development platform The Muse, joined Cheddar News to provide some tips if you're thinking of making a change in occupation.